George Lau

机构：Humanity & Health, Zhongshan Hospital · ORCID：0000-0002-8928-3769

发表论文 328 篇 · 总被引 30138 次 · h-index 77

代表论文

• The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease (2025 · Hepatology International · 被引 149)
• Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCC (2025 · Journal of Hepatology · 被引 136)
• Acute-on-chronic liver failure (ACLF): the ‘Kyoto Consensus’—steps from Asia (2025 · Hepatology International · 被引 63)
• APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024 (2024 · Hepatology International · 被引 59)
• Management of acute variceal bleeding: updated APASL guidelines (2025 · Hepatology International · 被引 17)
• Immune-mediated adverse events and overall survival with tremelimumab plus durvalumab and durvalumab monotherapy in unresectable HCC: HIMALAYA phase III randomized clinical trial (2025 · Hepatology · 被引 16)